Non-duplicate isolates from blood, urine, and respiratory specimens. Interpreted according to CLSI.
There are no interpretative criteria for Sulperazon in CLSI standard.
Nitrofurantoin susceptibility test performed on urine isolates only.
For All Units (except ICU/HDU): Overall prevalence of extended-spectrum β-lactamases (ESBL) was 28% for E. coli and 13% for Klebsiella species. ESBL-producing strains should be interpreted as resistant to all penicillins, cephalosporins, and aztreonam.
Percentage of Methicillin-resistant Staphylococcus aureus among Staphylococcus aureus isolated from blood, urine, and respiratory specimens: 56% in non-ICU & -HDU and 28% in ICU & HDU.
Adult Intensive Care Units and High Dependency Unit: Overall prevalence of extended-spectrum β-lactamases (ESBL) was 30% for E. coli and 13% for Klebsiella species. ESBL-producing strains should be interpreted as resistant to all penicillins, cephalosporins, and aztreonam.
For staphylococci that test susceptible, gentamicin is used only in combination with other active agents that test susceptible.
Overall prevalence of extended-spectrum β-lactamases (ESBL) was 32% for E. coli (33% in the group ≧ 3d of adm, 32% in the group within ≦ 2d of adm). ESBL-producing strains should be interpreted as resistant to all penicillins, cephalosporins, and aztreonam.
Overall prevalence of extended-spectrum β-lactamases (ESBL) was 9% for Klebsiella pneumoniae complex (0% in the group ≧ 3d of adm, 10% in the group within ≦ 2d of adm). ESBL-producing strains should be interpreted as resistant to all penicillins, cephalosporins, and aztreonam.
Staphylococcus aureus includes both Methicillin-sensitive and Methicillin-resistant Staphylococcus aureus.
Previous Page